Investing in AddVita, a healthcare and life sciences distribution company with its headquarters in Singapore, through the SeaTown Private Capital Master Fund (SeaTown PCap Fund), was announced on Wednesday by Temasek-based investment firm SeaTown Holdings International.
“This investment positions AddVita as an enduring home for small and medium-sized healthcare and life sciences distribution businesses across Asia, giving them a strong foundation and network to accelerate their growth,” SeaTown said in a statement, citing a capital commitment of up to S$115 million ($89.09 million) from SeaTown PCap Fund.
AddVita wants to be the most reputable and significant healthcare and life sciences distribution network in Asia.
Through a strong focus on innovation and collaboration, the firm hopes to transform healthcare accessibility and quality and create a healthier future by empowering small and medium-sized businesses.
It will seek to buy market-leading niche companies in Asia that specialize in distributing pharmaceutical, medical, and laboratory goods and services of the highest caliber.
AddVita will carry on expanding by implementing a “Buyand-Build” strategy focused on its long-term vision, supported by the financial backing and strategic direction of SeaTown PCap Fund.
By means of these focused investments and strategic alliances, AddVita will create a platform of superior goods and services that raise the standard and accessibility of healthcare throughout Asia.
The investment made by SeaTown PCap Fund also shows how confident the fund is in AddVita’s vision and fits with SeaTown’s long-term private equity strategy, which emphasizes scalable growth and value creation through a buy-and-build approach.
With more than $400 million invested in buy-and-build projects and more than ten years of private equity experience in Asia, SeaTown claimed to be in a strong position to help AddVita expand.
“We are excited to support AddVita in its mission to empower small and medium-sized businesses, enhancing healthcare access and quality across Asia,
“The healthcare distribution sector is resilient, with robust secular growth tailwinds,” said Dickson Loo, Managing Director of Private Equity at SeaTown.
“Our high-quality partners have also demonstrated the ability to generate strong cash flow and sustainable earnings growth. With SeaTown’s partnership, we are confident that AddVita will emerge as a leader in the region’s healthcare distribution sector, unlocking significant value creation opportunities,” he added.
SeaTown is a Singapore-based alternative investment firm that was founded in 2009 and has extensive knowledge of both the public and private markets.
The company, which is owned by Temasek’s asset management group Seviora Holdings, makes conviction-driven investments alongside its investors.
International investors can access the region’s highly specialized private equity, private credit, and thematic public equity opportunities through the company’s alternative investment fund platform.
For small and medium-sized companies in Asia that distribute pharmaceutical, medical, and laboratory goods and services, AddVita provides a stable home.
